Additionally, platinum-based chemotherapeutic agents preferentially eliminate EpCAM-negative OC cells, suggesting that the remaining EpCAM-positive cells may contribute to tumor recurrence after chemotherapy [42]. The gene discussed is EPCAM; the disease is neoplasm.